Horama Company
Horama develops gene therapies for rare inherited ocular diseases.
Founded Date:
2014
Number Of Exists:
Series B
Investment Stage:
N/A
Industry:
Gene Therapy
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Total Funding:
â¬27.1M
Headquarters:
Paris, Ile-de-France, France
Technology:
Neurological Disorders
Investor Type:
Company
Investors Number:
9
Employee Number:
11-50
Funding Status:
Early Stage Venture